Table 3: Endothelial function between baseline and following-up
|
Pioglitazone |
Control |
|
SR |
ATa |
SR |
ATa |
|
Baseline |
Following-up |
Baseline |
Following-up |
Baseline |
Following-up |
Baseline |
Following-up |
| FMD
(%)
|
4.4 ± 1.0 |
6.0 ± 0.2 |
4.3 ± 0.3 |
4.3 ± 0.5 |
4.0 ± 0.1 |
4.4 ± 0.1 |
3.9 ± 0.1 |
3.8 ± 0.1 |
| eNOS
(pg/ml)
|
18.4 ± 0.4 |
22.3 ± 0.7 |
18.2 ± 2.0 |
19.7 ± 1.5 |
18.6 ± 0.4 |
20.3 ± 0.4 |
19.0 ± 0.6 |
18.4 ± 0.5 |
| EPC
(cells/105 events)
|
3.2 ± 0.1 |
4.0 ± 0.1 |
3.0 ± 0.3 |
3.0 ± 0.2 |
3.3 ± 0.1 |
3.6 ± 0.1 |
3.4 ± 0.1 |
3.1 ± 0.2 |
Values are reported as mean + SEM
SR: Sinus Rhythm, ATa: Atrial Tachyarrhythmias